Figure S6 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells

Soyoung Lee; Kyunghwan Kim; Hye‐Jin Jeong; Subin Choi; Himchan Cheng; Dayoung Kim; Soomin Heo; Jinhee Mun; Minjong Kim; Eunjin Lee; Yoon Ji Choi; Seon‐gyeong Lee; Eun A Lee; Yewon Jang; Kayeong Lim; Heon Seok Kim; Euihwan Jeong; Seung‐Jae Myung; Deok‐Beom Jung; Chang Sik Yu; In Ho Song; M. Ryan Corces; Joo H. Kang; Kyungjae Myung; Taejoon Kwon; Tae‐Eun Park; Jinmyoung Joo; Seung Woo Cho

doi:10.1158/0008-5472.29760170

Key Points

MAIN FINDING: Multiplexed targeting using crispr and parp inhibitors significantly improves cancer cell death.
KEY EVIDENCE: Effective cell death correlated with predicted spcas9 activity and specific mutation patterns.
APPROACH: The study utilized a combination of multiplexed crispr targeting and parp inhibitors on cancer cells.
SIGNIFICANCE: This research demonstrates a promising strategy for enhancing cancer treatment outcomes and precision.

Implication

Research shows multiplexed crisper targeting increases cell death in cancer cells, indicating potential for enhanced treatment efficacy.

Abstract

Figure S6 illustrates how predicted SpCas9 activity and CRISPR-induced mutation patterns affect the efficiency of cell death following multiplexed CRISPR targeting.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lee et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d021e https://doi.org/10.1158/0008-5472.29760170

View Full Paper

Ask AI

Bookmark

Share

Figure S6 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells

Key Points

Implication

Abstract

Discussion

Cite This Study

Figure S6 from Combining Multiplexed CRISPR/Cas9-Nickase and PARP Inhibitors Efficiently and Precisely Targets Cancer Cells

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading